Skip to site content

Notice of New Tennessee Rule: Chapter 1145-01 Commissioner’s Controlled Substance Monitoring Database

The Tennessee Controlled Substance Monitoring Database (CSMD) rules have been amended effective January 26, 2022.  The amendment requires that all healthcare practitioners, unless otherwise exempted, check the CSMD prior to issuing a Schedule II amphetamine, at the beginning of a new episode of treatment[1]; prior to the issuance of each new prescription for the first ninety (90) days of a new episode of treatment; and at least every 6 months during that course of treatment.

This rule change means that Schedule II amphetamines constitute a third class of drugs triggering a check (opioids and benzodiazepines being the two current classes) and is the result of the CSMD Committee’s determination that Schedule II amphetamines demonstrate a high potential for abuse.   As with opioids and benzodiazepines, an authorized healthcare practitioner's delegate may check the controlled substance database on behalf of the healthcare practitioner who is prescribing Schedule II amphetamines.

The rule amendment also increases the list of mandatory fields for pharmacy and prescriber dispenser reporting information to the CSMD.

This table provides the links for each state’s Prescription Drug Monitoring Program (PDMP/CSMD) information.

North Carolina
South Carolina


As always, SVMIC is here for you and happy to answer any questions you may have by email at or 800.342.2239. You may also contact the licensure board in your state for additional information.



[1] A “new episode of treatment” means a prescription for a controlled substance that has not been prescribed by that healthcare practitioner within the previous six (6) months.


About The Author

Julie Loomis is Assistant Vice President of Risk Education for SVMIC where she develops educational programs and assists policyholders and staff with risk management issues. Ms. Loomis is a member of the Tennessee Bar Association and American Society of Healthcare Risk Managers (ASHRM). She serves on the Risk Management/Patient Safety Committee of the Medical Professional Liability Association. Ms. Loomis is a speaker on risk management and professional liability topics at industry seminars, medical schools and residency programs.

The contents of The Sentinel are intended for educational/informational purposes only and do not constitute legal advice. Policyholders are urged to consult with their personal attorney for legal advice, as specific legal requirements may vary from state to state and/or change over time.

Apply Today

Our team is here to answer any questions you might have or to help you fill out a quote application.

need help?

We're always just an email or phone call away.

contact us